L'Oréal Dermatological Beauty is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
Moisturising Cream
Formulated with 3 skin-identical ceramides and MVE Technology, this moisturising cream provides up to 48-hour hydration and helps restore the protective skin barrier with a soft, non-greasy finish.
Eligible Patients
Patients with dry to very dry skin. Also suitable for families, including babies (2 months+). Suitable for atopic dermatitis monotherapy and in an adjunctive routine.Application
Apply to the face and body, as often as needed.Texture
Non-greasy, fast-absorbing, rich cream.Moisturising Cream Efficacy
CeraVe Moisturising Cream Significantly Improved Symptoms of Dry Skin1
Protocol: A 4-week, single-centre study was conducted on 49 women (ages 30-65) with dry to very dry skin. CeraVe Moisturising Cream was used twice daily on one lower leg (the other leg remained untreated). A dermatologist assessed dry skin symptoms at baseline and week 4. Assessments were made on both the treated and untreated areas.
CeraVe Moisturising Cream Significantly Increased Ceramide Content in Patients With Dry Skin1
Protocol: A 4-week, single-centre study was conducted on 49 women (ages 30-65) with dry to very dry skin. CeraVe Moisturising Cream was used twice daily on one lower leg (the other leg remained untreated). A dermatologist assessed dry skin symptoms at baseline and week 4. Assessments were made on both the treated and untreated areas.
CeraVe Moisturising Cream Significantly Improved Signs of Sensory Discomfort1
Protocol: A 4-week, single-centre study was conducted on 49 women (ages 30-65) with dry to very dry skin. CeraVe Moisturising Cream was used twice daily on one lower leg (the other leg remained untreated). A dermatologist assessed dry skin symptoms at baseline and week 4. Assessments were made on both the treated and untreated areas.
CeraVe Moisturising Cream Significantly Increased and Maintained Skin Hydration2
Protocol: A 4-week, single-centre, double-blind, intra-subject clinical study was conducted on 34 women and men, ages 20-89, with dry, eczema-prone skin. Moisturising Cream and reference cream were applied twice daily to the lower legs. Corneometer readings were conducted on the lower legs 12-18 hours after the last application of Moisturising Cream and reference cream at baseline, week 2, and week 4. Reference cream was a traditional formulation sold in mass outlets in the UK that is commonly prescribed by the National Health Service (UK).
Moisturising Cream + Hydrating Cleanser Efficacy
A CeraVe Routine Significantly Improved Signs and Symptoms of Mature Xerosis3
Protocol: A 4-week, single-centre clinical study was conducted on 30 women and men, ages 70+, with evidence of xerosis and/or desquamation having a systemic disease and/or using concomitant medications with the side effect of xerosis. Hydrating Cleanser was used at least once daily on the body and Moisturising Cream was applied twice daily to the body. Efficacy was evaluated by clinical grading at baseline and week 4. Photographs and subject self-assessment evaluations were conducted at baseline and week 4.
A CeraVe Routine Significantly Improved Patient Symptoms in a Global Diabetic Study4
Protocol: In a multicentre study, 528 subjects (ages 18-75 years) from 19 countries with diabetes mellitus-related xerosis used the CeraVe Hydrating Cleanser and Moisturising Cream regimen twice daily for 4 weeks. Clinicians assessed dry skin symptoms using the five-point Dry Skin Classification Scale (DSCS) at baseline and week 4.
A CeraVe Routine Significantly Reduced AD Symptoms5
Protocol: In a randomised study, 151 subjects (118 subjects over 12) with mild to moderate atopic dermatitis (AD) used the CeraVe Hydrating Cleanser and Moisturising Cream regimen twice daily for 6 weeks. A dermatologist assessed treatment outcomes by comparing AD severity at baseline (day 0) versus the end of treatment (day 42).
A CeraVe Routine Significantly Shortened the Duration and Symptoms of Mild to Moderate Eczema6
Protocol: A 4-week study, on 60 women, men, and children, ages 5 to 80, with mild to moderate eczema, split in 3 groups. Subjects in Group 1 applied topical 0.05% fluocinonide cream to their entire face twice daily plus a mild cleansing bar as needed. Subjects in Group 2 applied topical 0.05% fluocinonide cream to their entire face twice daily plus Hydrating Cleanser as needed. Subjects in Group 3 applied topical 0.05% fluocinonide cream and Moisturising Cream to their entire face twice daily plus Hydrating Cleanser as needed. Efficacy and tolerability evaluations were conducted at baseline, weeks 1, 2, and 4.
Atopic Dermatitis
- Almost 3 out of 4 subjects (74%) with mild to moderate atopic dermatitis were cleared of symptoms after 6 weeks of using the regimen of CeraVe Hydrating Cleanser and Moisturising Cream4
Diabetes-Related Xerosis
- 93% of subjects demonstrated ≥1 point improvement in roughness/scaling after 4 weeks4
- 91% of subjects demonstrated ≥1 point improvement in fissures after 4 weeks4
- Over 75% of subjects improved in at least one quality of life parameter: feelings of embarrassment, quality of their social life, and quality of their work/study4
- Subjects were compliant with 91% of expected CeraVe regimen applications and reported intentions to continue use outside of the study4
Mature Xerosis
- 93% of subjects felt their dry skin no longer limited their daily activities of work, physical activity, or rest3
- 90% of subjects felt their dry skin no longer impacted their social or leisure activities3
- 70% of subjects felt their dry skin was no longer embarrassing or awkward3
REFERENCES: 1. Draelos ZD, Baalbaki NH, Raab S, Colón G. The effect of a ceramide-containing product on stratum corneum lipid levels in dry legs. J Drugs Dermatol. 2020;19(4):372-376. doi:10.36849/JDD.2020.4796 2. Danby SG, Andrew PV, Kay LJ, et al. Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema-prone skin. Br J Dermatol. 2022;186(5):875-886. doi:10.1111/bjd.20955 3. Filippi F, Patrizi A, Chessa MA. 33125 Improving quality of life for elderly patients with xerosis with an easy-to-use, ceramide-containing skincare routine. J Am Acad Dermatol. 2022;87(3):AB70 4. Kirsner R, Andriessen A. An international evaluation of a ceramide-containing hydrating cleanser and moisturizing cream for the improvement of diabetes mellitus-related xerosis. J Drugs Dermatol. 2023;22(1):65-73. doi:10.36849/JDD.7168 5. Lynde CW, Andriessen A. A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis. Cutis. 2014;93(4):207-213. 6. Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis. 2008;81(1):87-91.